13F Holdings
中文EN

COO COOPER COMPANIES, INC.

Ophthalmic Goods · Nasdaq · SEC CIK 711404 · Fiscal year ends 10/31

Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.7%
TTM net income YoY39.8%
TTM EPS YoY42.6%
Revenue 3-yr CAGR6.4%
Net income 3-yr CAGR27.5%

Margins

Gross margin65.9%
Operating margin12.8%
Net margin13.5%
FCF margin16.0%
EBITDA margin19.7%

Returns

ROE6.8%
ROA4.6%
ROIC (approx.)5.1%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets34.3%
Debt / equity0.31x
Current ratio1.22x
Interest coverage6.10x

Cash quality & payout

Operating cash flow / net income1.81x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue8.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-10-31FY20242024-10-31FY20232023-10-31FY20222022-10-31FY20212021-10-31
Income statement
Revenue$4.09B$3.90B$3.59B$3.31B$2.92B
Cost of revenue$1.41B$1.30B$1.24B$1.17B$966.70M
Gross profit$2.68B$2.60B$2.36B$2.14B$1.96B
R&D expense$172.20M$155.10M$137.40M$110.30M$92.70M
SG&A expense$1.63B$1.53B$1.50B$1.34B$1.21B
Operating income$682.90M$705.70M$533.10M$507.60M$505.80M
Interest expense$100.00M$114.30M$105.30M$57.30M$23.10M
Pretax income$566.50M$582.30M$412.90M$475.30M$491.50M
Income tax$191.60M$190.00M$118.70M$89.50M-$2.45B
Net income$374.90M$392.30M$294.20M$385.80M$2.94B
EBITDA$1.06B$1.08B$900.80M$853.70M$815.10M
EPS (basic)1.881.971.491.9559.80
EPS (diluted)1.871.961.481.9459.16
Dividends declared per share——0.010.010.03
Weighted avg. shares (diluted)200.00M200.40M199.30M198.80M49.80M
Balance sheet
Cash & equivalents$110.60M$107.70M$120.80M$138.60M$96.60M
Receivables$829.00M$717.00M$609.70M$557.80M$515.30M
Inventory$846.00M$802.70M$735.60M$628.70M$585.60M
Current assets$2.11B$1.95B$1.70B$1.53B$1.47B
PP&E, net$2.08B$1.86B$1.63B$1.43B$1.35B
Goodwill$3.85B$3.84B$3.62B$3.61B$2.57B
Intangibles$1.59B$1.79B$1.71B$1.89B$1.27B
Total assets$12.39B$12.32B$11.66B$11.49B$9.61B
Current liabilities$1.11B$1.02B$969.00M$1.28B$732.10M
Short-term debt$47.80M$33.30M$45.40M$412.60M$83.40M
Long-term debt$2.46B$2.55B$2.52B$2.35B$1.40B
Total debt$2.50B$2.58B$2.57B$2.76B$1.48B
Total liabilities$4.16B$4.23B$4.11B$4.32B$2.66B
Shareholders' equity$8.24B$8.08B$7.55B$7.17B$6.94B
Net debt$2.39B$2.47B$2.44B$2.62B$1.38B
Shares outstanding195.90M199.60M198.10M49.30M49.30M
Cash flow statement
Operating cash flow$796.10M$709.30M$607.50M$692.40M$738.60M
Capital expenditure$362.40M$421.20M$392.50M$242.00M$214.40M
Free cash flow$433.70M$288.10M$215.00M$450.40M$524.20M
Investing cash flow-$372.90M-$764.60M-$449.00M-$1.83B-$450.30M
Financing cash flow-$425.90M$39.20M-$173.90M$1.19B-$311.40M
Depreciation & amortization$377.40M$375.10M$367.70M$346.10M$309.30M
Stock-based compensation$70.50M$75.10M$62.10M$54.20M$43.80M
Dividends paid$0$0$3.00M$3.00M$3.00M
Share buybacks$290.10M$0$0$78.50M$24.80M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.